Resultado de búsqueda
Acting on our mission to advance science for life. See how we are working to build a better and more equitable future for all. View our 2023 Performance Report. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Boston Scientific Corporation ("BSC"), headquartered in Watertown, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention ...
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Our work is guided by core values that define Boston Scientific culture and empower our employees. Caring • Meaningful innovation • High performance • Global collaboration • Diversity ...
Your caring for others inspires us to care for you. “I came into a very caring culture, a very values-based culture, and everyone knows what we’re working towards.”. — Nicole Forman, Employee Engagement Communications Specialist. Learn what it’s like to work at Boston Scientific.
Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.856 billion during the first quarter of 2024, growing 13.8 percent on a reported basis, 15.0 percent on an operational1 basis... Read more press releases. In the news. Mar 19, 2024. Transforming the future of chronic pain care with Matt McDonald.
31 de ene. de 2024 · MARLBOROUGH, Mass., Jan. 31, 2024 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.725 billion during the fourth quarter of 2023, growing 14.9 percent on a reported basis, 14.5 percent on an operational 1 basis and 13.6 percent on an organic 2 basis, all compared to the prior year period.
1 de feb. de 2023 · MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period. Included within organic results is a negative approximately 200 basis point ...
